Biotransformation of Tetrahydrocannabinol

Phytochemistry Reviews

Volumn 15, Issue 5, 2016, Pages 921-934

  Akhtar, Muhammad T ^a   Shaari, Khozirah ^a   Verpoorte, Robert ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Mammalian cells; Metabolism; Microorganisms; Plant cells; Tetrahydrocannabinol

Indexed keywords

1' 11 HYDROXY TETRAHYDROCANNABINOL; 11 HYDROXY DELTA8 TETRAHYDROCANNABINOL; 11 HYDROXY TETRAHYDROCANNABINOL; 11 OXO DELTA8 TETRAHYDROCANNABINOL; 2' 11 HYDROXY TETRAHYDROCANNABINOL; 3' HYDROXY DELTA9 TETRAHYDROCANNABINOL; 4' 11 HYDROXY TETRAHYDROCANNABINOL; 4',5' BISNOR DELTA9 TETRAHYDROCANNABINOL 11,3' DIOIC ACID; 7ALPHA 11 DIHYDROXY DELTA8 TETRAHYDROCANNABINOL; 7BETA 11 DIHYDROXY DELTA8 TETRAHYDROCANNABINOL; 8 HYDROXY TETRAHYDROCANNABINOL; 8ALPHA 11 HYDROXY TETRAHYDROCANNABINOL; 8ALPHA HYDROXY TETRAHYDROCANNABINOL; 8BETA 11 HYDROXY TETRAHYDROCANNABINOL; 8BETA HYDROXY EPOXYHEXAHYDROCANNABINOL; 8BETA HYDROXY TETRAHYDROCANNABINOL; CYTOCHROME P450; DELTA8 TETRAHYDROCANNABINOL; DRONABINOL; OXYGENASE; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

BACTERIAL STRAIN; BIOTRANSFORMATION; CHEMICAL STRUCTURE; COMPARATIVE STUDY; DOG; FUNGAL STRAIN; GUINEA PIG; HAPLORHINI; HUMAN; MAMMAL CELL; METABOLITE; NONHUMAN; PLANT CELL; PRIORITY JOURNAL; RABBIT; REVIEW; STEREOSELECTIVITY;

EID: 84941686390     PISSN: 15687767     EISSN: 1572980X     Source Type: Journal    
DOI: 10.1007/s11101-015-9438-9     Document Type: Review

References (74)

1. Abbott BJ, Fukuda DS, Archer RA (1977) Microbiological transformation of cannabinoids. Experientia 33:718–720
2. 1-tetrahydrocannabinol. Res Commun Chem Pathol Pharmacol 8:223–229
3. 1-tetrahydrocannabinol (THC) by rabbit liver-microsomes. Biochem Pharmacol 24:1130–1131
4. 1-tetrahydrocannabinol by mouse hepatic microsomes: identification of 6alpha-hydroxytetrahydrocannabinol. J Pharm Sci 63:1173–1174
5. 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction. Drug Alcohol Depen 37:231–240
6. Binder M (1976) Microbial transformation of (−)-D 1–3, 4-trans-tetrahydrocannabinol by Cunninghamella blakesleeana Lender. Helv Chima Acta 59:1674
7. Binder M, Meisenberg G (1978) Microbial transformation of cannabinoids 2. A screening of different microorganisms. Eur J Appl Microbiol Biotechnol 5:37–50
8. 1-tetrahydrocannabinol. Helv Chima Acta 63:2515–2518
9. 1-tetrahyrocannabinol. Drug Metab Dispos 20:241–246
10. Braemer R, Paris M (1987) Biotransformation of cannabinoids by a cell suspension culture of Cannabis sativa L. Plant Cell Rep 6:150–152
11. Brown NK, Harvey DJ (1988a) In vivo metabolism of the methyl homologues of Delta-8-tetrahydrocannabinol, Delta-9-tetrahydrocannabinol and abn-delta-8-tetrahydrocannabinol in the mouse. Biomed Environ Mass Spectrom 15:389–398
12. 9-tetrahydrocannabinol in the mouse. Eur J Drug Metab Pharmacokinet 13:165–176
13. 9-tetrahydrocannabinol in the mouse. Biomed Environ Mass Spectrom 15:403–410
14. 1-tetrahydrocannabinol by hepatic microsomal oxygenase. Ann NY Acad Sci 191:61–67
15. Burstein SH, Kupfer D (1971b) Hydroxylation of trans-1-tetrahydrocannabinol by a hepatic microsomal monooxygenase. Chem Biol Interact 3:316
16. 1-tetrahydrocannabinol in mouse hepatic microsomes. Drug Metab Dispos 9:94–96
17. 1-Tetrahydrocannabinol. Science 176:422–423
18. Carter GT, Weydt P (2002) Cannabis: old medicine with new promise for neurological disorders. Curr Opin Investig Drugs 3:437–440
19. 9-6a, 10a, 10a-trans-tetra-hydrocannabinol by Chaetomium-globosum. Aust J Chem 31:1799–1807
20. Gaoni Y, Mechoulam R (1964) Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish. J Am Chem Soc 86:1646–1647
21. Gaoni Y, Mechoulam R (1966) Cannabichromene, a new active principle in hashish. Chem Commun 1:20–21
22. 6-tetrahydrocannabinol in rhesus monkey. Acta Pharm Suec 16:34–40
23. 1-tetrahydrocannabinol in man. Arznei-Forschung 32:1135–1138
24. 1-tetrahydrocannabinol in man. Arznei-Forschung 32:764
25. 1-tetrahydrocannabinol formed by human livers. Drug Metab Dispos 10:297–301
26. Harvey DJ (1989) Further studies on the oxidative cleavage of the pentyl side-chain of cannabinoids: identification of new biotransformation pathways in the metabolism of 3′-hydroxy-delta-9-tetrahydrocannabinol by the mouse. Xenobiotica 19:1437–1447
27. 9-tetrahydrocannabinol in the mouse. Drug Metab Dispos 18:350–355
28. 1-tetrahydrocannabinol in mouse liver. Res Commun Chem Pathol Pharmacol 13:585–599
29. 1-tetrahydrocannabinol in mouse liver. Res Commun Chem Pathol Pharmacol 21:435
30. 7-tetrahydrocannabinol and the use of deuterium labeling. Recent Dev Mass Spectrom Biochem Med 2:127–147
31. 6-tetrahydrocannabinol produced by the mouse. Drug Metab Dispos 8:178–186
32. 6-tetrahydrocannabinol by the guinea pig: identification of two new hydroxyacid and ketoacid metabolites. Res Commun Subst Abuse 2:193–201
33. Harvey DJ, Paton WD (1986) Metabolism of cannabinoids. Rev Biochem Toxicol 6:221–264
34. 1-tetrahydrocannabinol in mouse liver. J Pharm Pharmacol 29:482–486
35. Harvey DJ, Martin BR, Paton WD (1978a) Identification and measurement of cannabinoids and their in vivo metabolites in liver by gas chromatography-mass spectrometry. Adv Biosci 22–23:45–62
36. 1-THC), cannabidiol (CBD) and cannabinol (CBN) by several species. Recent Dev Mass Spectrom Biochem Med 1:161–184
37. 1-tetrahydrocannabinol, cannabidiol and cannabinol produced by the guinea pig. J Pharm Pharmacol 32:262
38. 1-tetrahydrocannabinol: switching of the major site of biotransformation from C-7 to the side-chain. Res Commun Subst 1:159–167
39. 7- tetrahydrocannabinol produced by the mouse. Drug Metab Dispos 8:439–445
40. 1-tetrahydrocannabinol in mouse brain. Comparison with vitro liver metabolites. Acta Pharm Suec 11:283–294
41. 9-tetrahydrocannabinol in some organs of monkey Callithrix jaccus. N-S Arch Pharmacol 287:219–225
42. 9-tetrahydrocannabinol-11-oic acid by thin-layer chromatography. J Chromatogr 151:225–227
43. Matsunaga T, Iwawaki Y, Watanabe K, Yamamoto I, Kageyama T, Yoshimura H (1995) Metabolism of delta-9-tetrahydrocannabinol by cytochrome P450 isozymes purified from hepatic microsomes of monkeys. Life Sci 56:2089–2095
44. Mechoulam R, Goani Y (1967) Recent advances in the chemistry of hashish. Fortschr Chem Org Naturst 25:175–213
45. 8-tetrahydrocannabinol by hepatic microsomes of the guinea pig. Drug Metab Dispos 16:156–161
46. 9-tetrahydrocannabinol in the rat. Biochem Pharmacol 41:1187–1194
47. 1-tetrahydrocannabinol: structure of a major metabolite. Science 168:1228–1229
48. 1-tetrahydrocannabinol isolated from rabbit urine. J Pharm Pharmacol 26:471
49. 1-tetrahydrocannabinol isolated from rabbit urine. J Pharm Pharmacol 31:231
50. 1-tetrahydrocannabinol isolated from rabbit urine. J Pharm Pharmacol 31:238–243
51. Pars HG, Howes JF (1977) Potential therapeutic agents derived from the cannabinoid nucleus. Adv Drug Res 11:97–189
52. 9-tetrahydrocannabinol by alkane-degrading bacteria. Appl Environ Microbiol 75:7135–7141
53. Robertson LW, Lyle MA (1975) Biotransformation of cannabinoids by Syncephalastrum racemosum. Biol Mass Spectrom 2:266–271
54. Robertson LW, Huff SR, Ghosh A, Malhotra R (1978a) Acidic biotransromation products of cannabinoids produced by Mycobacterium rohodchrous. Lloydia 41:659
55. Robertson LW, Koh SW, Huff SR, Malhotra RK, Ghosh A (1978b) Microbiological oxidation of pentyl side-chain of cannabinoids. Experientia 34:1020–1022
56. Russo EB (2007) History of cannabis and its preparations in saga, science, and sobriquet. Chem Biodivers 4:1614–1648
57. Scotter EL, Abood ME, Glass M (2010) The endocannabinoid system as a target for the treatment of neurodegenerative disease. Br J Pharmacol 160:480–498
58. Sirikantaramas S, Taura F, Morimoto S, Shoyama Y (2007) Recent advances in Cannabis sativa research: biosynthetic studies and its potential in biotechnology. Curr Pharm Biotechnol 8:237–243
59. Tanaka H, Morimoto S, Shoyama Y (1993) Cannabis, 21. Biotransformation of Cannabinol to its glycosides by in vitro plant tissue. J Nat Prod 56:2068–2072
60. 6-Tetrahydrocannabinol 2′-O-beta-D-glucopyranoside, Biotransformed by Plant Tissue. J Nat Prod 60:168–170
61. 8-tetrahydrocannabinol. Chem Ber 109:3606–3614
62. Wall ME (1971) The in vitro metabolism of tetrahydrocannabinol (THC). Ann NY Acad Sci 191:23
63. Wall ME, Brine DR (1976) Identification of cannabinoids and metabolites in biological materials by combined gas-liquid chro-matography-mass spectrometry. In: Nahas GG (ed) Marihuana: chemistry, biochemistry, and cellular effects. Springer, New York, p 51
64. 9-tetrahydrocannabinol and related cannabinoids in man. J Clin Pharmacol 21:178–189
65. 9-tetrahydrocannabinol. J Am Chem Soc 92:3466–3468
66. 9-tetrahydrocannabinol and metabolites in man. J Am Chem Soc 94:8579–8581
67. 8-tetrahydrocannabinol. Biochem Biophys Res Commun 88:178–182
68. 8-tetrahydrocannabinol in the mouse brain and liver. J Pharmacobiodyn 3:686–691
69. 8-tetrahydrocannabinol-11-oic acid. Biochem Pharmacol 42:1255–1259
70. 1-tetrahydrocannabinol by the isolated perfused dog lung. Comparison with in vitro liver metabolism. J Pharm Pharmacol 27:842
71. Widman M, Halldin MM, Martin B (1979) In vitro metabolism of tetrahydrocannabinol by rhesus monkey liver and human liver. Adv Biosci 22–23:101–103
72. 9-tetrahydrocannabinol-11-oic acid glucuronide: a tetrahydrocannabinol metabolite. J Pharm Pharmacol 32:445–448
73. Yamamoto I, Watanabe K, Narimatsu S, Yoshimura H (1995) Recent advances in the metabolism of cannabinoids. Int J Biochem Cell Biol 27:741–746
74. Yamamoto I, Watanabe K, Matsunaga T, Kimura T, Funahashi T, Yoshimura H (2003) Pharmacology and toxicology of major constituents of marijuana-on the metabolic activation of cannabinoids and its mechanism. Toxicology 22:577–589